Literature DB >> 4393577

Hydroxyprolinemia: an apparently harmless familial metabolic disorder.

R Pelkonen, K I Kivirikko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4393577     DOI： 10.1056/NEJM197008272830903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.

Authors:  Xingsheng Li; John Knight; Sonia Fargue; Brianna Buchalski; Zhengrong Guan; Edward W Inscho; Abigail Liebow; Kevin Fitzgerald; William Querbes; W Todd Lowther; Ross P Holmes
Journal:  Biochim Biophys Acta       Date:  2015-12-02

Review 2.  The metabolism of hydroxyproline.

Authors:  E Adams
Journal:  Mol Cell Biochem       Date:  1973-12-15       Impact factor: 3.396

3.  Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.

Authors:  David T Woodley; Jon Cogan; Yingping Hou; Chao Lyu; M Peter Marinkovich; Douglas Keene; Mei Chen
Journal:  J Clin Invest       Date:  2017-07-10       Impact factor: 14.808

Review 4.  RNA interference in the treatment of renal stone disease: Current status and future potentials.

Authors:  Kyle D Wood; Ross P Holmes; John Knight
Journal:  Int J Surg       Date:  2016-11-12       Impact factor: 6.071

5.  Hydroxyprolinaemia with normal development.

Authors:  M J Robinson; I S Menzies; I Sloan
Journal:  Arch Dis Child       Date:  1980-06       Impact factor: 3.791

6.  Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria.

Authors:  Candice B Summitt; Lynnette C Johnson; Thomas J Jönsson; Derek Parsonage; Ross P Holmes; W Todd Lowther
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

7.  Genetic cause and prevalence of hydroxyprolinemia.

Authors:  Christian Staufner; Tobias B Haack; Patrik Feyh; Gwendolyn Gramer; Deepthi Ediga Raga; Caterina Terrile; Sven Sauer; Jürgen G Okun; Junmin Fang-Hoffmann; Ertan Mayatepek; Holger Prokisch; Georg F Hoffmann; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-05-02       Impact factor: 4.982

8.  Recall rate and positive predictive value of MSUD screening is not influenced by hydroxyproline.

Authors:  Ralph Fingerhut
Journal:  Eur J Pediatr       Date:  2008-08-06       Impact factor: 3.183

9.  Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.

Authors:  Jennifer Remington; Xinyi Wang; Yingpin Hou; Hui Zhou; Julie Burnett; Trevor Muirhead; Jouni Uitto; Douglas R Keene; David T Woodley; Mei Chen
Journal:  Mol Ther       Date:  2008-11-18       Impact factor: 11.454

10.  Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.

Authors:  Sonia Fargue; Dawn S Milliner; John Knight; Julie B Olson; W Todd Lowther; Ross P Holmes
Journal:  J Am Soc Nephrol       Date:  2018-03-27       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.